Publicaciones en colaboración con investigadores/as de University of Milano-Bicocca (18)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry

    European heart journal, Vol. 44, Núm. 35, pp. 3357-3370

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3063-3071

2022

  1. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review

    Journal of Lower Genital Tract Disease, Vol. 25, Núm. 1, pp. 27-37

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1

    Journal of the American College of Cardiology, Vol. 75, Núm. 15, pp. 1772-1784

  2. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update

    Journal of Clinical Oncology, Vol. 38, Núm. 5, pp. 496-520

2019

  1. Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry

    European Heart Journal, Vol. 40, Núm. 35, pp. 2964-2975A

  2. Genetic Mosaicism in Calmodulinopathy

    Circulation: Genomic and Precision Medicine, Vol. 12, Núm. 9, pp. 375-385

  3. Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

    Journal of Clinical Medicine, Vol. 8, Núm. 11

2018

  1. Timing of onset affects arthritis presentation pattern in antisynthetase syndrome

    Clinical and Experimental Rheumatology, Vol. 36, Núm. 1, pp. 44-49

2017

  1. Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: Subgroup analysis of the DISTINCT randomised trial

    Journal of Human Hypertension, Vol. 31, Núm. 3, pp. 178-188

2016

  1. Modeling the cerebellar microcircuit: New strategies for a long-standing issue

    Frontiers in Cellular Neuroscience, Vol. 10, Núm. JULY

2015

  1. Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2120-2129

2014

  1. Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCTrandomized trial results

    Journal of Hypertension, Vol. 32, Núm. 12, pp. 2488-2498